Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae
NCT00729313 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 111
Last updated 2019-03-04
Summary
The purpose of the protocol, is to determine whether lanreotide 30 mg is effective in the treatment of patients with digestive fistulae.
Conditions
- Digestive Fistulae
Interventions
- DRUG
-
Lanreotide microparticles
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Ipsen Medical Director · Ipsen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-04-30
- Primary Completion
- 2005-04-30
- Completion
- 2005-04-30
Countries
- France
- Russia
Study Locations
More Related Trials
-
Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
NCT02921555 ·Status: TERMINATED ·Phase: PHASE4
-
An Early Phase 2 Clinical Study of KSP-0243
NCT05831670 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients
NCT05927064 ·Status: COMPLETED
-
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
NCT02808780 ·Status: ACTIVE_NOT_RECRUITING
-
Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
NCT04882007 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis
NCT01456052 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
NCT02895100 ·Status: TERMINATED ·Phase: PHASE2
-
Fecal Microbiota Transplantation for Ulcerative Colitis
NCT03804931 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
NCT02289417 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis
NCT01097590 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
NCT02840721 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis
NCT00928681 ·Status: COMPLETED ·Phase: PHASE1
-
The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis
NCT02435160 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis
NCT04074590 ·Status: TERMINATED ·Phase: PHASE2
-
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
NCT03950232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis
NCT04424303 ·Status: COMPLETED
-
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
NCT02958865 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis
NCT02447302 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis
NCT03893565 ·Status: TERMINATED ·Phase: PHASE2
-
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
NCT01562314 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis
NCT01011322 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
NCT02435992 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis
NCT05549323 ·Status: TERMINATED ·Phase: PHASE1
-
Confirmatory Clinical Study in Active Ulcerative Colitis
NCT07296315 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis
NCT02291523 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1